Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitorsHidetoshi Sumimoto, Yataro Daigo, Hiroyoshi Koide et al.|PLoS ONE|2024Cited by 16
Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic CancerAya Tokuda, Masaji Tani|Anticancer Research|2021Cited by 5